Incomplete distal renal tubular acidosis from a heterozygous mutation of the V-ATPase B1 subunit
Jianning Zhang(The University of Texas Southwestern Medical Center), Orson W. Moe(Io Therapeutics (United States)), Henry Quiñones(The University of Texas Southwestern Medical Center), Carolyn Griffith, Mary Ann Cameron(The University of Texas Southwestern Medical Center), Daniel G. Fuster(University of Bern), Xiao‐Song Xie(The University of Texas Southwestern Medical Center)
Cited by 54
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Cardiolipin provides specificity for targeting of tBid to mitochondria
|Nature Cell Biology|2000|469
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
|Advances in Chronic Kidney Disease|2012|394